Low-dose heparin: is the risk worth the benefit?

Am Heart J. 1979 Jul;98(1):94-101. doi: 10.1016/0002-8703(79)90325-9.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Acute Disease
  • Blood Coagulation / drug effects
  • Cerebrovascular Disorders / complications*
  • Dose-Response Relationship, Drug
  • Drug Evaluation
  • Estradiol Congeners / adverse effects
  • Estradiol Congeners / therapeutic use
  • Female
  • Hemorrhage / chemically induced
  • Heparin / administration & dosage*
  • Heparin / adverse effects
  • Heparin / therapeutic use
  • Humans
  • Immobilization
  • Injections, Subcutaneous
  • Male
  • Myocardial Infarction / complications*
  • Postoperative Complications / mortality
  • Postoperative Complications / prevention & control*
  • Pulmonary Embolism / etiology
  • Pulmonary Embolism / mortality
  • Pulmonary Embolism / prevention & control*
  • Respiratory Insufficiency / complications
  • Risk
  • Thrombophlebitis / etiology
  • Thrombophlebitis / mortality
  • Thrombophlebitis / prevention & control*

Substances

  • Estradiol Congeners
  • Heparin